Presence of c-KIT-positive mast cells in obliterative bronchiolitis from diverse causes

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 9, 2009, Pages 1420-1425

  Fuehrer, Neil E ^a   Marchevsky, Alberto M ^b   Jagirdar, Jaishree ^a  

^a University of Texas Health Science Center   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CD20 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; DOMESTIC CHEMICAL; INTERLEUKIN 2 RECEPTOR ALPHA; STEM CELL FACTOR; STEM CELL FACTOR RECEPTOR;

ARTICLE; ASTHMA; BASEMENT MEMBRANE; BRONCHIOLITIS OBLITERANS; CASE REPORT; CONTROLLED STUDY; DISEASE COURSE; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; FIBROSIS; HUMAN; HUMAN TISSUE; MAST CELL; RESPIRATORY EPITHELIUM;

ASTHMA; BIOLOGICAL MARKERS; BRONCHIOLES; BRONCHIOLITIS OBLITERANS; EMPHYSEMA; FIBROSIS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAST CELLS; PIPERAZINES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES;

EID: 69749092747     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Brautbar N, Wu MP, Richter ED. Chronic ammonia inhalation and interstitial pulmonary fibrosis: a case report and review of the literature. Arch Environ Health. 2003;58(9):592-596.
2. Das R, Blanc PD. Chlorine gas exposure and the lung: a review. Toxicol Ind Health. 1993;9(3):439-455. (Pubitemid 23191586)
3. de la Hoz RE, Schlueter DP, Rom WN. Chronic lung disease secondary to ammonia inhalation injury: a report on three cases. Am J Ind Med. 1996;29:209-214.
4. Keith I, Day R, Lemaire S, Lemaire I. Asbestos-induced fibrosis in rats: increase in lung mast cells and autacoid contents. Exp Lung Res. 1987;13(3):311-327.
5. Weiss SM, Lakshminarayan S. Acute inhalation injury. Clin Chest Med. 1994;15:103-114.
6. Wright JL. Inhalational lung injury causing bronchiolitis. Clin Chest Med. 1993;14(4):635-644.
7. Yildirim C, Kocoglu H, Goksu S, Cengiz B, Sari I, Babci C. Long-term pulmonary histopathologic changes in rats following acute experimental exposure to chlorine gas. Inhal Toxicol. 2004;16(14):911-915. (Pubitemid 39546311)
8. Sobonya R. Fatal anhydrous ammonia inhalation. Hum Pathol. 1977;8(3): 293-299.
9. Schenker MB, Jacobs JA. Respiratory effects of organic solvent exposure. Tuber Lung Dis. 1996;77(1):4-18. (Pubitemid 26066604)
10. Leduc D, Gris P, Lheureux P, Gevenois PA, De Vuyst P, Yernault JC. Acute and long term respiratory damage following inhalation of ammonia. Thorax. 1992;47:755-757.
11. Reilly MJ, Rosenman KD. Chemical exposure: cleaners including ammonia and chlorine exposure. Arch Environ Health. 1995;50(1):26-30.
12. Svetlecic J, Molteni A, Chen Y, Al-Hamed M, Quinn T, Herndon B. Transplant- related bronchiolitis obliterans (BOS) demonstrates unique cytokine profiles compared to toxicant-induced BOS. Exp Mol Pathol. 2005;79:198-205. (Pubitemid 41566233)
13. Al-Muhsen SZ, Shablovsky G, Olivenstein R, Mazer B, Hamid Q. The expression of stem cell factor and c-kit receptor in human asthmatic airways. Clin Exp Allergy. 2004;34:911-916. (Pubitemid 38824069)
14. Lukacs NW, Kunkel SL, Strieter RM, et al. The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation. Blood. 1996;87(6):2262-2268. (Pubitemid 26086865)
15. Zhi-Qing H, Zhao WH, Shimamura T. Regulation of mast cell development by inflammatory factors. Curr Med Chem. 2007;14:3044-3050. (Pubitemid 350226973)
16. Pesci A, Majori M, Piccoli ML, et al. Mast cells in bronchiolitis obliterans organizing pneumonia: mast cell hyperplasia and evidence for extracellular release of tryptase. Chest. 1996;110:383-391. (Pubitemid 26269265)
17. Artuc M, Hermes B, Steckelings UM, Grutzkan A, Henz BM. Mast cells and their mediators in cutaneous wound healing-active participants or innocent bystanders? Exp Dermatol. 1999;8(1):1-16. (Pubitemid 29038037)
18. Tsuneyama K, Kono N, Yamashiro M, et al. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis. J Pathol. 1999;189:609-614.
19. Barbato A, Panizzolo C, D'Amore ESG, La Rosa M, Saetta M. Bronchiolitis obliterans organizing pneumonia (BOOP) in a child with mild-to-moderate asthma: evidence of mast cell and eosinophil recruitment in lung specimens. Pediatr Pulmonol. 2001;31:394-397. (Pubitemid 32417259)
20. Nathan SD. Therapeutic management of idiopathic pulmonary fibrosis: an evidence-based approach. Clin Chest Med. 2006;27(1 suppl 1):S27-S35.
21. Pesci A, Bertorelli G, Gabrielli M, Olivieri D. Mast cells in fibrotic lung disorders. Chest. 1993;103:989-996. (Pubitemid 23110259)
22. Edwards ST, Cruz AC, Donnelly S, et al. c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases. J Pathol. 2005;206:279-290. (Pubitemid 40903192)
23. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350:2645-2653. (Pubitemid 38787999)
24. Utell MJ, Samat JM. Environmentally mediated disorders of the respiratory tract. Med Clin North Am. 1990;74(2):291-306.
25. Chaudhary NI, Schnapp A, Park JE. Pharmacologic differentiation of in- flammation and fibrosis in the rat bleomycin model. Am J Respir Crit Care Med. 2006;173(7):769-776.
26. Miettinen M, Lasota J. KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol. 2005;13(3):205-220. (Pubitemid 41209013)
27. Orfao A, Garcia-Montero AC, Sanchez L, Escribano L. Recent advances in the understanding of mastocytosis: the role of KIT mutations. Br J Haematol. 2007; 138:12-30. (Pubitemid 46889785)
28. Sotlar K, Horny HP, Simonitsch I, et al. CD25 indicates the neoplastic phenotype of mast cells: a novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens. Am J Surg Pathol. 2004;28:1319-1325. (Pubitemid 39336370)
29. Arber DA, Tamayo R,Weiss LM. Paraffin section detection of the c-kit gene product (CD117) in human tissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998;29(5):498-504.
30. Butnor KJ, Burchette JL, Sporn TA, Hammar SP, Roggli VL. The spectrum of Kit (CD117) immunoreactivity in lung and pleural tumors: a study of 96 cases using a single-source antibody with a review of the literature. Arch Pathol Lab Med. 2004;128(5):538-543.
31. Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology. 2007;74:121-132.
32. Powe DG, Huskisson RS, Carney AS, et al. Mucosal t-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy. 2004;59(2):204-212.
33. Gurish MF, Boyce JA. Mast cell growth, differentiation, and death. Clin Rev Allergy Immunol. 2002;22(2):107-118. (Pubitemid 34264091)
34. Da Silva CA, Adda M, Stern M, de Blay F, Frossard N, Israel-Biet D. Marked stem cell factor expression in the airways of lung transplant recipients. Respir Res. 2006;7:90. (Pubitemid 47202080)
35. Berlin AA, Hogaboam CM, Lukacs NW. Inhibition of SCF attenuates peribronchial remodeling in chronic cockroach allergen-induced asthma. Lab Invest. 2006;86(6):557-565.
36. Ali S, Ali S. Role of the c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST). Gene. 2007;401:38-45. (Pubitemid 47379512)
37. Demetri GD. Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options. Semin Oncol. 2001;28(5 suppl 17):19-26.
38. Fletcher JA, Rubin BP. KIT mutations in GIST. Curr Opin Genet Dev. 2007; 17:3-7.
39. Silva M, Reid R. Gastrointestinal stromal tumors (GIST): c-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with imatinib. Pathol Oncol Res. 2003;9(1):13-19 (Pubitemid 36604534)
40. Gollard RP, Ruemmier-Fish C, Garcia D. Systemic mastocytosis: documented pathologic response to imatinib. Eur J Haematol. 2007;79:367-368. (Pubitemid 47390125)
41. Pardanani A, Elliott M, Reeder T, et al. Imatinib for systemic mast-cell disease. Lancet. 2003;362(9383):535-536.
42. Adcock IM, Chung KF, Caramori G, Ito K. Kinase inhibitors and airway inflammation. Eur J Pharmacol. 2006;533(1-3):118-132.
43. Aono Y, Nishioka Y, Inayama M, et al. Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Crit Care Med. 2005;171:1279-1285. (Pubitemid 40740736)